Dolphin
Senior Member (Voting Rights)
https://www.sciencedirect.com/science/article/pii/S0002934324002730
The American Journal of Medicine
Available online 13 May 2024
In Press, Journal Pre-proof
Clinical Research Study
Examining well-being and cognitive function in people with long Covid and ME/CFS, and age-matched healthy controls: A Case-Case-Control Study
https://doi.org/10.1016/j.amjmed.2024.04.041
open access
Abstract
Purpose
Well-being and cognitive function had not previously been compared between people with long COVID and people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Therefore, this study examined well-being and cognitive function in people with long COVID (∼16 months illness duration; n= 17) and ME/CFS (∼16 years illness duration; n=24), versus age-matched healthy controls (n=16).
Methods
Well-being was examined using several questionnaires, namely the Health Visual Analogue Scale (VAS), Fatigue Severity Scale (FSS), Post-exertional malaise (PEM), Pittsburgh Sleep Quality Index (PSQI), European Quality of Life-5 Domains (EQ-5D), MRC Dyspnoea, Self-Efficacy (SELTC), The Edinburgh Neurosymptoms Questionnaire (ENS), General Anxiety Disorder 7 (GAD-7), and Patient Health Questionnaire 9 (PHQ-9). Cognitive function was examined using Single Digit Modalities Test (SDMT), Stroop test, and Trails A and B. These were delivered via a mobile application (app) built specifically for this remote data collection.
Results
The main findings of the present investigation were that people with ME/CFS and people with long COVID were generally comparable on all well-being and cognitive function measures, but self-reported worse values for pain, fatigue, Post-exertional malaise, sleep quality, general well-being in relation to mobility, usual activities, self-care, breathlessness, neurological symptoms, self-efficacy, and other well-being such as anxiety and depression, compared to controls. There was no effect of group for cognitive function measures.
Conclusions
These data suggest that both people with long COVID and people with ME/CFS have similar impairment on well-being measures examined herein. Therefore, interventions that target well-being of people with ME/CFS and long COVID are required.
Keywords
Well-being
Cognitive function
Myalgic Encephalomyelitis
Chronic Fatigue Syndrome
Post-Exertional Malaise
Long COVID
---
Clinical significance
Long COVID and ME/CFS cause impaired well-being and cognitive function, putting these groups at greater risk of employment and activities of daily living challenges.
People with Long COVID and ME/CFS have lower well-being but comparable cognitive function when compared to controls, which likely causes greater dysfunction in their daily lives.
As a result, accommodations for activities of daily living should be made available to long COVID and ME/CFS individuals.
The American Journal of Medicine
Available online 13 May 2024
In Press, Journal Pre-proof
Clinical Research Study
Examining well-being and cognitive function in people with long Covid and ME/CFS, and age-matched healthy controls: A Case-Case-Control Study
Nilihan E.M. Sanal-Hayes, PhD 1,2,*, Marie Mclaughlin, PhD2,3, Lawrence D. Hayes, PhD 2,4, Ethan C.J. Berry, BSc (Hons)2, Nicholas F. Sculthorpe, PhD2
1 School of Health and Society, University of Salford, Salford, UK
2 Sport and Physical Activity Research Institute, School of Health and Life Sciences, University of the West of Scotland, Glasgow, UK
3 School of Sport, Exercise & Rehabilitation Sciences, University of Hull, Hull, UK
4 Lancaster Medical School, Lancaster University, Lancaster, UK
Received 11 April 2024, Accepted 25 April 2024, Available online 13 May 2024.
https://doi.org/10.1016/j.amjmed.2024.04.041
open access
Abstract
Purpose
Well-being and cognitive function had not previously been compared between people with long COVID and people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Therefore, this study examined well-being and cognitive function in people with long COVID (∼16 months illness duration; n= 17) and ME/CFS (∼16 years illness duration; n=24), versus age-matched healthy controls (n=16).
Methods
Well-being was examined using several questionnaires, namely the Health Visual Analogue Scale (VAS), Fatigue Severity Scale (FSS), Post-exertional malaise (PEM), Pittsburgh Sleep Quality Index (PSQI), European Quality of Life-5 Domains (EQ-5D), MRC Dyspnoea, Self-Efficacy (SELTC), The Edinburgh Neurosymptoms Questionnaire (ENS), General Anxiety Disorder 7 (GAD-7), and Patient Health Questionnaire 9 (PHQ-9). Cognitive function was examined using Single Digit Modalities Test (SDMT), Stroop test, and Trails A and B. These were delivered via a mobile application (app) built specifically for this remote data collection.
Results
The main findings of the present investigation were that people with ME/CFS and people with long COVID were generally comparable on all well-being and cognitive function measures, but self-reported worse values for pain, fatigue, Post-exertional malaise, sleep quality, general well-being in relation to mobility, usual activities, self-care, breathlessness, neurological symptoms, self-efficacy, and other well-being such as anxiety and depression, compared to controls. There was no effect of group for cognitive function measures.
Conclusions
These data suggest that both people with long COVID and people with ME/CFS have similar impairment on well-being measures examined herein. Therefore, interventions that target well-being of people with ME/CFS and long COVID are required.
Keywords
Well-being
Cognitive function
Myalgic Encephalomyelitis
Chronic Fatigue Syndrome
Post-Exertional Malaise
Long COVID
---
Clinical significance
Long COVID and ME/CFS cause impaired well-being and cognitive function, putting these groups at greater risk of employment and activities of daily living challenges.
People with Long COVID and ME/CFS have lower well-being but comparable cognitive function when compared to controls, which likely causes greater dysfunction in their daily lives.
As a result, accommodations for activities of daily living should be made available to long COVID and ME/CFS individuals.